These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17212928)

  • 1. [A novel function for renal collecting duct intercalated cells: defense against uropathogenic Escherichia coli].
    Chassin C; Goujon JM; Le Bouguénec C; Buzoni-Gatel D; Vandewalle A
    Med Sci (Paris); 2007 Jan; 23(1):32-4. PubMed ID: 17212928
    [No Abstract]   [Full Text] [Related]  

  • 2. Uropathogenic Escherichia coli AL511 requires flagellum to enter renal collecting duct cells.
    Pichon C; Héchard C; du Merle L; Chaudray C; Bonne I; Guadagnini S; Vandewalle A; Le Bouguénec C
    Cell Microbiol; 2009 Apr; 11(4):616-28. PubMed ID: 19134121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney α-intercalated cells and lipocalin 2: defending the urinary tract.
    Miao Y; Abraham SN
    J Clin Invest; 2014 Jul; 124(7):2844-6. PubMed ID: 24937424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for collecting duct epithelial cells in renal antibacterial defences.
    Chassin C; Tourneur E; Bens M; Vandewalle A
    Cell Microbiol; 2011 Aug; 13(8):1107-13. PubMed ID: 21615666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder defense mechanisms against urinary tract infections.
    Schaeffer AJ
    Semin Urol; 1983 May; 1(2):106-13. PubMed ID: 6382529
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
    Langermann S; Möllby R; Burlein JE; Palaszynski SR; Auguste CG; DeFusco A; Strouse R; Schenerman MA; Hultgren SJ; Pinkner JS; Winberg J; Guldevall L; Söderhäll M; Ishikawa K; Normark S; Koenig S
    J Infect Dis; 2000 Feb; 181(2):774-8. PubMed ID: 10669375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Intercalated cells defend the urinary system from bacterial infection.
    Paragas N; Kulkarni R; Werth M; Schmidt-Ott KM; Forster C; Deng R; Zhang Q; Singer E; Klose AD; Shen TH; Francis KP; Ray S; Vijayakumar S; Seward S; Bovino ME; Xu K; Takabe Y; Amaral FE; Mohan S; Wax R; Corbin K; Sanna-Cherchi S; Mori K; Johnson L; Nickolas T; D'Agati V; Lin CS; Qiu A; Al-Awqati Q; Ratner AJ; Barasch J
    J Clin Invest; 2014 Jul; 124(7):2963-76. PubMed ID: 24937428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections.
    Langermann S; Ballou WR
    J Infect Dis; 2001 Mar; 183 Suppl 1():S84-6. PubMed ID: 11171023
    [No Abstract]   [Full Text] [Related]  

  • 10. [Uropathogenic Escherichia coli (UPEC) strains in Erzurum].
    Ayyildiz A; Balkan R; Babacan M
    Mikrobiyol Bul; 1989 Jul; 23(3):197-202. PubMed ID: 2577279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Some properties of uropathogenic strains of Escherichia coli].
    Cejková J; Mosnová H; Barnová M
    Cesk Epidemiol Mikrobiol Imunol; 1982 Nov; 31(6):360-5. PubMed ID: 6216966
    [No Abstract]   [Full Text] [Related]  

  • 12. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?
    Marrs CF; Zhang L; Foxman B
    FEMS Microbiol Lett; 2005 Nov; 252(2):183-90. PubMed ID: 16165319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulence factors in uropathogenic E. coli.
    Shrikhande SN; Chande CA; Pathak AA
    Indian J Pathol Microbiol; 1999 Jul; 42(3):321-5. PubMed ID: 10862292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.
    Anderson GG; Dodson KW; Hooton TM; Hultgren SJ
    Trends Microbiol; 2004 Sep; 12(9):424-30. PubMed ID: 15337164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate receptor depletion as an antimicrobial strategy for prevention of urinary tract infection.
    Svensson M; Platt F; Frendeus B; Butters T; Dwek R; Svanborg C
    J Infect Dis; 2001 Mar; 183 Suppl 1():S70-3. PubMed ID: 11171019
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tamm-Horsfall protein--uromodulin].
    Duława J; Kokot M
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):700-2. PubMed ID: 1492042
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of E. coli adhesiveness in the pathogenesis and clinical course of urinary tract infections].
    Krzeska I; Ostojska J; Dzierzanowska D
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):706-9. PubMed ID: 1362812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
    Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME
    FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors recognize uropathogenic Escherichia coli and trigger inflammation in the urinary tract.
    Anders HJ; Patole PS
    Nephrol Dial Transplant; 2005 Aug; 20(8):1529-32. PubMed ID: 15941847
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of uropathogenic Escherichia coli with host uroepithelium.
    Kau AL; Hunstad DA; Hultgren SJ
    Curr Opin Microbiol; 2005 Feb; 8(1):54-9. PubMed ID: 15694857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.